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21 days with refreshment of medium every other day. Levels
of collagen degradation was measured by ELISA recognizing
the C-terminal telopeptide fragments of type II collagen (CTX-
II), cartilage formation was measured by N-terminal pro-peptide
of type II collagen (PIINP), and BMP-2 levels was measured by
ELISA. Measurements were performed in serum, protein extracts
from paws and in the conditioned medium of articular cartilage
explants.
Results: In vivo collagen induced RA, was accompanied by an
500%, P<0.001 increase in type II collagen degradation (CTX-II)
and a 40% decrease in collagen type II formation (PII), at disease
onset +14 days, Figure 1 A&B. In the paw extracts, collagen
degradation (CTX-II) was increased by 4000% compared to
control, P<0.001. Collagen formation (PII) was increased by
100% compared to control, P<0.001.
In the ex vivo cartilage explants, OSM + TNF at all time-points
before day 16 resulted in more than 75% reduction in collagen
type II formation as measured by PIINP, P<0.01. At later time
points (day 16-21), collagen type II formation was significantly
increased by 200%, P<0.01. Collagen type II degradation (CTX-
II), was induced by more than 5000%, P<0.001, after day 14 of
culture. BMP-2 levels were increased by 50%, P<0.01, after day
16 compared to that of earlier days.
Conclusions: In vivo, in serum, induction of RA results in highly
increased levels of collagen type II degradation and decreased
levels of collagen type II formation. Locally in the infected joints,
cartilage degradation was increased by 4000%, and formation by
200%, demonstrating pathological cartilage metabolism.Ex vivo,
pro-inflammatory cytokines resulted in highly increased collagen
type II degradation and decreased collagen type II formation,
which at later time points resulted in significant more BMP-2 and
collagen type II synthesis. These results strongly support the in
vivo findings.
We clearly show that inflammatory cytokines initially result in
decreased cartilage formation and increased degradation. We
suggest that the measurements of both cartilage formation and
degradation under pathologic situations may provide essential
information on disease status and risk of progression.
A26
DEVELOPMENT OF A NEW CANINE MODEL OF
OSTEOARTHRITIS: THE GROOVE MODEL
S.C. Mastbergen1, J. DeGroot2, F.P. Lafeber1
1University Medical Center Utrecht, Utrecht, The Netherlands,
2Business Unit Biomedical Research TNO Quality of Life,
Leiden, The Netherlands
Purpose: The frequently used anterior cruciate ligament tran-
section (ACLT) model of osteoarthritis in the dog makes use of
a permanent trigger (joint instability) for inducing degenerative
changes. The present study evaluates a relatively new canine
model of osteoarthritis, which is induced by a one-time trigger:
the groove model.
Methods: The articular cartilage of the weight-bearing areas
of the femoral condyles in one knee of 30 Beagle-dogs was
damaged by making grooves without damaging the subchondral
bone. Surgery was followed by 3, 10, or 20 weeks intensified
loading of the affected joint. The severity of osteoarthritis was
evaluated at 3 (n=10), 10 (n=10), 20 (n=5) and 40 weeks (n=5) af-
ter surgery. Cartilage integrity, chondrocyte activity, and synovial
inflammation were determined by macroscopy, histochemistry
and biochemistry.
Results: Ten weeks after surgery osteoarthritic features were
found. Proteoglycan synthesis, percentage release of newly
formed proteoglycans, the total amount of proteoglycans, and
amount of denatured collagen were enhanced, whereas proteo-
glycan content was diminished (all p<0.05). Based on these
parameters there was a slow progression over time from 20
and 40 weeks after induction, statistically significant for synthe-
sis, content and Mankin grade. Importantly, three weeks after
surgery these characteristics of osteoarthritis were not yet ev-
ident. In contrast, synovial inflammation was mild at 3 and 10
weeks and diminished slightly in time.
Conclusions: The present results show that characteristics ob-
served at 10 weeks or later after induction of osteoarthritis in the
groove model:
– comparable to those found the canine ACLT model.
– slowly progressive over time in the first year.
– not primarily mediated by synovial inflammation.
– induced by a one-time trigger.
– not just the expression of the surgically applied damage.
In this model the effect of treatment of cartilage damage is
not counteracted by permanent joint instability or hampered
by inflammation. Therefore, the groove model might be more
sensitive to detect effects of therapy, aimed at cartilage protection
and repair.
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CHONDROCYTE SENESCENCE IN OSTEOARTHRITIS
K. Yudoh, K. Masuko, T. Kato, K. Nishioka
St. Marianna University School of Medicine, Kawasaki City,
Japan
Purpose: Articular chondrocyte senescence is responsible, at
least in part, for the age-related increased incidence of os-
teoarthritis (OA). Recently, it was suggested that caveolin-1, a
21-24 kDa membrane protein, participates in the premature cellu-
lar senescence. Caveolin-1 is the principal structural component
of caveolae, vesicular invaginations of the plasma membrane.
We studied whether or not catabolic factors, oxidative stress and
IL-1β, induce premature senescence of articular chondrocytes
through the up-regulation of caveolin-1 expression.
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Methods: 1) To clarify the expression of caveolin-1 in OA car-
tilage, the immunostaining for caveolin-1 was examined in the
donor-matched pair of intact and degenerated articular cartilage
that were isolated from the same OA sample.
2) To clarify the involvement of caveolin-1 expression in the pro-
gression of cartilage degeneration, we investigated the levels of
caveolin-1 expression in chondrocytes with advance of cartilage
degeneration in the OA rat model.
3) The phenotype of stress-induced senescent cells was char-
acterized by an increase of cell size, SA-β-Gal activity and
irreversible growth arrest at the G0/G1 phase of the cell cycle in
caveolin-1-deficient chondrocytes.
4) To elucidate the significance of stress-induced senescent
chondrocytes in the development and/or progression of OA, we
studied the capability of them to produce matrix components in
caveolin-1 overexpressed chondrocytes.
Results: In articular cartilages from human OA samples and
OA model rats, those positivities for caveolin-1 were associ-
ated with histologic changes characteristic of OA. Both catabolic
factors, IL-1β and H2O2, upregulated mRNA and protein levels
of caveolin-1, and both treatments markedly induced expres-
sions of senescent phenotypes; cell morphology, cell growth
arrest, telomere erosion, and specific senescence-associated β-
galactosidase activity. Caveolin-1 overexpression induced senes-
cence with p38 MAPK activation and also impaired chondrocytes
ability to produce collagen type II and aggrecan. In contrast,
downregulation of caveolin-1 by antisense oligonucleotide sig-
nificantly inhibited the catabolic factors-induced chondrocyte
senescence. Caveolin-1 induction and both stresses with IL-
1β and H2O2 upregulated p53 and p21, and downregulated
the phosphorylated Rb, suggesting that p53-p21-Rb phospho-
rylation pathway may mediate the stress-induced chondrocyte
senescence. Prolonged p38 MAPK activation and the p53-p21-
Rb phosphorylation pathway are required to mediate the stress-
induced senescence.
Conclusions: Our findings suggest that IL-1β and oxidative
stress induce chondrocyte senescence in OA, which is mediated,
at least in part, by the stress-induced caveolin-1 expression,
indicating that a role of caveolin-1 promoting stress-induced
chondrocyte senescence in the pathogenesis of OA.
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A 2D-LC/MS/MS APPROACH TO IN VITRO JOINT INJURY
BIOMARKERS AND BIOLOGY
A.L. Stevens, J.S. Wishnok, S.R. Tannenbaum, A.J. Grodzinsky
Massachusetts Institute of Technology, Cambridge, MA
Purpose: Traumatic joint injury is sufficient to increase the risk
of OA. Mechanical trauma to the tissue as well as secondary
joint inflammation may contribute to cartilage degeneration. The
purpose of this study was to develop a quantitative proteomics
approach to characterize the effects of mechanical compression
injury and cytokine treatment on cartilage damage. Our focus
was to identify secreted proteins or matrix molecules that re-
spond sufficiently to one or more treatments that they might
serve as sensitive indicators of inflammation and/or injury.
Methods: Cartilage was subjected to a single compression, to
treatment with IL-1b, to treatment with TNF-a, or no treatment
and left in medium for five days with a 10% removal/supplement
daily. At the end of this period, the media were partially deglyco-
sylated with 70 mU of Chondroitinase ABC, trypsinized, labeled
with iTRAQ isotope labels for quantitation, and combined into a
single sample. The sample was fractionated (∼45 fractions) by
strong cation-exchange chromatography (SCX), and each frac-
tion was analyzed by RP-LC/MS/MS using a QStar, quadrupole
time-of-flight instrument (ABI), operated in data dependent ac-
quisition mode. The data were analyzed using ProQuant (ABI)
that identified and quantitated the proteins in each fraction. Iden-
tification required 2 unique peptides with a confidence of >89%,
and identification and quantitation was manually validated for at
least 1 peptide per protein. Statistical significance was based on
peptide analysis using either Student’s t-Test or Wilcoxan rank-
sum both with Bonferroni correction for multiple comparisons.
K-means clustering and PCA analysis was done to assist data
interpretation. Data are reported as ratios of treated: untreated;
log transformation was necessary to achieve symmetry about
zero.
Results: At a systems level, proteins released in response
to TNF-α and to IL-1β were similar (R2 = 0.76; p<0.0001),
while plots of mechanical compression injury vs. cytokine treat-
ment appeared ‘Y’-shaped indicating similarities in proteins de-
creased and unchanged but differences in proteins elevated with
treatment. Approximately 500 proteins, including matrix proteins,
membrane proteins, secreted proteins, and intracellular proteins,
were released into the medium in response to cytokine or in-
jury. Several previously identified potential biomarkers include
YKL39, YKL40, MMP-3 and serum amyloid A3 (SAA). In our ex-
periments, these were elevated 10-fold or greater with cytokine
treatment and slightly with injury while MMP-3 was elevated at
least 5-fold with all treatments (p<0.05). We observed a num-
ber of additional candidates, e.g., osteopontin and CTGF, SPUF,
and annexin A8, that were elevated ∼5-fold or greater with all
treatments, and ECM-1, which was elevated over 10 fold with
cytokine treatment and elevated 2-3 fold with injury (p<0.05).
Proteins such as proenkephalin and inhibin beta (activin A) were
released in response to injury alone (p<0.10 for inhibin beta) as
well as a number of cytoplasmic, cytoskeletal and ER proteins
including FK506 binding protein 10,GRP78, triosephoshate iso-
merase, GRP58, gp96, filamin A which may assist in determining
extent of injury. Glycosylases and other golgi proteins were de-
creased with treatments. In addition to these possible markers,
proteins involved in innate immunity and immune recruitment
as well as possible repair processes were altered with treat-
ments, and indications of changes in matrix protein synthesis
and degradation were identified.
Conclusions: Cartilage tissue responds to mechanical injury
and cytokine treatment with important similarities and differences
in proteins released which may provide opportunities for more
targeted biomarkers for joint injury and OA.
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A REDUCED EXPRESSION OF CARTILAGE OLIGOMERIC
MATRIX PROTEIN (COMP) IN CULTURED
OSTEOARTHRITIC CHONDROCYTES CAN BE ASCRIBED
TO A LOSS OF THE CELL CHONDROGENIC
DIFFERENTIATION POTENTIAL
P. Giannoni1, R. Narcisi2, R. Cancedda2
1Biorigen srl, Genova, Italy, 2Lab. Regenerative Medicine, Natl.
Inst. for Cancer Research, Genova, Italy
Purpose: Culturing of articular chondrocytes is required to per-
form cartilage resurfacing in tissue engineering-based repair
approaches. The phenotypic changes occurring in cultured chon-
drocytes are compensated by the maintenance of their differen-
tiation potential. Normal chondrocytes are in fact able to regain
their morphology and a correct matrix homeostasis, fulfilling
repair needs. However many patients undergoing articular car-
tilage repair display different pathological tissues, ranging from
early-grade to clear osteoarthritic ones. Their osteoarthritic (OA)
cells display a reduced chondrogenic commitment and a di-
minished biosynthetic activity. In OA cells we identified altered
mRNA levels of the Cartilage Oligomeric Matrix Protein (COMP),
a large pentameric extracellular protein playing a structural role
in skeletal tissues. Purpose of this work was to elucidate the
